21Shares’ TSUI ETF began trading on Nasdaq today as the third spot SUI product launched this week. The fund lets U.S. investors gain exposure to SUI through brokerage accounts without taking custody of the tokens.
The Supreme Court overturned Trump-era tariffs on Feb. 20, 2026, sparking a risk-on move that sent cryptocurrencies higher. 21Shares warned the ruling could weigh on Treasuries and the U.S. dollar while benefiting stocks and crypto.
21Shares announced on Jan. 29, 2026 a Solana staking ETP built on JitoSOL, giving European investors regulated access to SOL staking yields. The product aims to combine on-chain yield with the tradability of an ETP.
The 21Shares fund, backed by the Dogecoin Foundation, is now listed and trading on Nasdaq after becoming the first U.S. spot DOGE ETF to receive formal SEC approval. The debut opens a new, regulated route for retail and institutional exposure to Dogecoin.
21Shares has listed a physically backed Bitcoin–Gold exchange-traded product on the London Stock Exchange, offering combined exposure to BTC and allocated gold in a single security. The move aims to simplify diversified allocations for investors seeking crypto and precious-metal exposure.
21Shares submitted an amended S-1 with the SEC on Dec. 23, 2025, reiterating its intention to launch a Dogecoin ETF. The update arrives while existing DOGE ETFs continue to show zero inflows, underscoring weak initial demand.
Crypto.com and 21Shares announced a strategic partnership to create a private CRO trust and pursue a future exchange-traded fund tied to the Cronos ecosystem. The move aims to broaden regulated, institutional access to Cronos-based assets.
21Shares filed an updated prospectus with the U.S. SEC for an XRP ETF to be listed under ticker TOXR, moving the product closer to launch. The filing comes as other issuers such as Canary, Grayscale, and Bitwise also pursue XRP funds.
21Shares launched the first 2x leveraged SUI ETF on Nasdaq after SEC approval, offering traders amplified exposure to the Sui token. The product expands regulated access to SUI but carries the usual leverage risks for short-term strategies.